PUBLISHER: Acute Market Reports | PRODUCT CODE: 1572336
PUBLISHER: Acute Market Reports | PRODUCT CODE: 1572336
Advanced Therapy Medicinal Products Market - Growth, Future Prospects and Competitive Analysis, 2024 - 2032
The advanced therapy medicinal products (ATMPs) market encompasses a segment within the pharmaceutical and biotechnological industry, focused on innovative therapies that offer groundbreaking new opportunities for the treatment of diseases and injuries. ATMPs are products that use genes, tissues, or cells for medicinal purposes. This market includes gene therapies, somatic cell therapies, tissue-engineered products, and combinations thereof. These therapies are used for a range of serious or life-threatening diseases, including various types of cancers, genetic disorders, and neurodegenerative diseases. Advanced therapy medicinal products market is estimated to grow at a CAGR of 17% from 2024 to 2032. Gene therapies involve introducing, altering, or removing genetic material within a patient's cells to treat or prevent a disease. Somatic cell therapies involve administering living cells to patients to treat a disease or repair damaged tissue. Tissue-engineered products include those that combine cells with biomaterials to replace or regenerate human tissues.
Advanced Therapy Medicinal Products Market Dynamics
Driver: Unmet Medical Needs and Disease Burden
The primary driver of the advanced therapy medicinal products (ATMPs) market is the significant unmet medical needs and increasing burden of diseases, especially rare and genetic disorders, cancers, and neurodegenerative diseases. Traditional therapeutic approaches often fall short in effectively treating these complex conditions, paving the way for ATMPs which offer novel and potentially curative treatments. The rising incidence of cancer worldwide, for example, necessitates new treatment modalities, and ATMPs like CAR-T cell therapies have shown promising results in treating certain types of cancers that were previously considered untreatable. Additionally, the growing prevalence of genetic disorders, where conventional therapies are limited, has led to an increased focus on gene therapies that can address the root cause of these conditions. The pressing need for innovative treatments in these areas drives significant research, investment, and interest in the development of ATMPs.
Opportunity: Technological Advancements and Personalized Medicine
An opportunity in the ATMPs Market lies in the rapid technological advancements and the shift towards personalized medicine. The evolution of genetic engineering, cell therapy, and biotechnology has greatly enhanced the development and effectiveness of ATMPs. The integration of these advanced technologies enables the development of highly targeted therapies tailored to individual patient profiles, especially in oncology and genetic disorders. Furthermore, advancements in genome sequencing and editing technologies like CRISPR have expanded the potential for developing gene therapies for a wider range of diseases. Personalized medicine's growing prominence, emphasizing tailored treatment approaches based on individual genetic information, aligns perfectly with the capabilities of ATMPs, presenting significant growth opportunities for the market.
Restraint: Regulatory and Manufacturing Complexities
A major restraint in the market is the complex regulatory landscape and manufacturing challenges associated with ATMPs. The production of these therapies involves intricate processes, requiring high levels of expertise and stringent quality control. Unlike traditional pharmaceuticals, ATMPs are often biologically derived and can be patient-specific, adding to the complexity of manufacturing and quality assurance. Navigating the regulatory pathways for ATMP approval is also challenging, given the novel nature of these products and the need for comprehensive data to demonstrate safety and efficacy. Regulatory agencies are continuously evolving their frameworks to accommodate the unique aspects of ATMPs, but the complexity and novelty of these therapies pose significant hurdles in bringing them to market.
Challenge: High Development Costs and Market Access
A significant challenge in the ATMPs Market is the high development cost and issues related to market access. The research, development, and production of ATMPs require substantial investment, often making these therapies expensive. The cost factor poses a challenge not only in terms of securing funding for research and development but also in terms of affordability and accessibility for patients. Moreover, the healthcare systems in many countries are still adapting to the integration of these high-cost therapies, posing challenges in reimbursement and patient access. Balancing the cost while ensuring accessibility to these potentially life-saving therapies remains a key challenge for manufacturers, healthcare providers, and policymakers.
Market Segmentation by Therapy Type
In the advanced therapy medicinal products (ATMPs) market, segmentation by therapy type includes Cell Therapy, Gene Therapy, and Tissue Engineered Products. The Cell Therapy segment is anticipated to exhibit the highest Compound Annual Growth Rate (CAGR) from 2024 to 2032. This growth is driven by the increasing success rate of cell therapy products in treating a range of diseases, particularly in oncology with the advent of CAR-T cell therapies. Cell therapies' ability to replace or regenerate cells, tissues, or organs to restore normal function presents a significant advancement in treating diseases that were previously considered intractable. Despite the rapid growth of the Cell Therapy segment, Gene Therapy generated the highest revenue in 2023. This can be attributed to the breakthroughs in gene therapy research and the approval of several gene therapy products for diseases like spinal muscular atrophy and inherited retinal diseases. Gene therapies, with their potential to directly address the genetic root causes of diseases, represent a transformative approach in the medical field, contributing to their dominant position in terms of revenue.
Market Segmentation by Region
In the advanced therapy medicinal products (ATMPs) market, geographic segmentation highlights different growth trends across regions. In 2023, North America, especially the United States, generated the highest revenue, a trend expected to continue from 2024 to 2032. The dominance of North America in the market can be attributed to its advanced healthcare infrastructure, strong presence of biotechnology and pharmaceutical companies, substantial investments in research and development, and a regulatory environment conducive to the advancement of ATMPs. Furthermore, the high prevalence of various chronic diseases and the presence of a well-established healthcare system supporting advanced therapy adoption contribute to this region's market leadership. In contrast, the Asia-Pacific region is projected to exhibit the highest Compound Annual Growth Rate (CAGR) during the forecast period, driven by increasing investments in healthcare, rising awareness of advanced therapeutic options, and growing healthcare needs in emerging economies like China and India.
Competitive Trends
Regarding competitive trends and key players, the market in 2023 was marked by the presence of companies such as Spark Therapeutics, Inc., Bluebird Bio, Inc., Novartis AG, UniQure N.V., Celgene Corporation, Gilead Lifesciences, Inc., Kolon TissueGene, Inc., JCR Pharmaceuticals Co., Ltd., MEDIPOST, Vericel Corporation, PHARMICELL Co., Ltd, and Organogenesis Inc. Novartis and Gilead Sciences have been at the forefront in the development and commercialization of cell and gene therapies, with products like Kymriah and Yescarta, respectively. Spark Therapeutics has made significant strides in gene therapy, particularly for inherited retinal diseases. Vericel Corporation has been notable for its advancements in tissue-engineered products. From 2024 to 2032, these companies are expected to focus on expanding their pipeline of ATMPs, investing in research and development to explore new therapy areas, and collaborating with academic and research institutions. Strategies are likely to include navigating regulatory landscapes effectively, advancing manufacturing capabilities to meet the demand for ATMPs, and establishing strong commercialization strategies in various regions. The combined revenue of these companies in 2023 reflects their significant market presence, and their ongoing strategies are anticipated to play a crucial role in shaping the market dynamics over the forecast period. This competitive landscape underlines a market driven by innovation, strategic collaborations, and a commitment to addressing complex medical challenges through advanced therapies.
Historical & Forecast Period
This study report represents an analysis of each segment from 2022 to 2032 considering 2023 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2024 to 2032.
The current report comprises quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends & technological analysis, case studies, strategic conclusions and recommendations and other key market insights.
Research Methodology
The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. The key data points that enable the estimation of Advanced Therapy Medicinal Products market are as follows:
Research and development budgets of manufacturers and government spending
Revenues of key companies in the market segment
Number of end users & consumption volume, price, and value.
Geographical revenues generated by countries considered in the report
Micro and macro environment factors that are currently influencing the Advanced Therapy Medicinal Products market and their expected impact during the forecast period.
Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top-down and bottom-up approach for validation of market estimation assures logical, methodical, and mathematical consistency of the quantitative data.
Market Segmentation
Therapy Type
- Cell Therapy
- Stem Cell Therapy
- Non-stem Cell Therapy
- Gene Therapy
- Tissue Engineered Product
Region Segment (2022-2032; US$ Million)
North America
U.S.
Canada
Rest of North America
UK and European Union
UK
Germany
Spain
Italy
France
Rest of Europe
Asia Pacific
China
Japan
India
Australia
South Korea
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East and Africa
GCC
Africa
Rest of Middle East and Africa
Key questions answered in this report
What are the key micro and macro environmental factors that are impacting the growth of Advanced Therapy Medicinal Products market?
What are the key investment pockets concerning product segments and geographies currently and during the forecast period?
Estimated forecast and market projections up to 2032.
Which segment accounts for the fastest CAGR during the forecast period?
Which market segment holds a larger market share and why?
Are low and middle-income economies investing in the Advanced Therapy Medicinal Products market?
Which is the largest regional market for Advanced Therapy Medicinal Products market?
What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
Which are the key trends driving Advanced Therapy Medicinal Products market growth?
Who are the key competitors and what are their key strategies to enhance their market presence in the Advanced Therapy Medicinal Products market worldwide?
Table of Contents
1. Preface
- 1.1. Report Description
- 1.1.1. Purpose of the Report
- 1.1.2. Target Audience
- 1.1.3. Key Offerings
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.3.1. Phase I - Secondary Research
- 1.3.2. Phase II - Primary Research
- 1.3.3. Phase III - Expert Panel Review
- 1.3.4. Assumptions
- 1.3.5. Approach Adopted
2. Executive Summary
- 2.1. Market Snapshot: Global Advanced Therapy Medicinal Products Market
- 2.2. Global Advanced Therapy Medicinal Products Market, By Therapy Type, 2023 (US$ Million)
- 2.3. Global Advanced Therapy Medicinal Products Market, By Geography, 2023 (US$ Million)
- 2.4. Attractive Investment Proposition by Geography, 2023
3. Advanced Therapy Medicinal Products Market: Competitive Analysis
- 3.1. Market Positioning of Key Advanced Therapy Medicinal Products Market Vendors
- 3.2. Strategies Adopted by Advanced Therapy Medicinal Products Market Vendors
- 3.3. Key Industry Strategies
- 3.4. Tier Analysis 2023 Versus 2032
4. Advanced Therapy Medicinal Products Market: Macro Analysis & Market Dynamics
- 4.1. Introduction
- 4.2. Global Advanced Therapy Medicinal Products Market Value, 2022 - 2032, (US$ Million)
- 4.3. Market Dynamics
- 4.3.1. Market Drivers
- 4.3.2. Market Restraints
- 4.3.3. Key Challenges
- 4.3.4. Key Opportunities
- 4.4. Impact Analysis of Drivers and Restraints
- 4.5. See-Saw Analysis
- 4.6. Porter's Five Force Model
- 4.6.1. Supplier Power
- 4.6.2. Buyer Power
- 4.6.3. Threat Of Substitutes
- 4.6.4. Threat Of New Entrants
- 4.6.5. Competitive Rivalry
- 4.7. PESTEL Analysis
- 4.7.1. Political Landscape
- 4.7.2. Economic Landscape
- 4.7.3. Technology Landscape
- 4.7.4. Legal Landscape
- 4.7.5. Social Landscape
5. Advanced Therapy Medicinal Products Market: By Therapy Type, 2022-2032, USD (Million)
- 5.1. Market Overview
- 5.2. Growth & Revenue Analysis: 2023 Versus 2032
- 5.3. Market Segmentation
- 5.3.1. Cell Therapy
- 5.3.1.1. Stem Cell Therapy
- 5.3.1.2. Non-stem Cell Therapy
- 5.3.2. Gene Therapy
- 5.3.3. Tissue Engineered Product
- 5.3.1. Cell Therapy
6. North America Advanced Therapy Medicinal Products Market, 2022-2032, USD (Million)
- 6.1. Market Overview
- 6.2. Advanced Therapy Medicinal Products Market: By Therapy Type, 2022-2032, USD (Million)
- 6.3.Advanced Therapy Medicinal Products Market: By Region, 2022-2032, USD (Million)
- 6.3.1.North America
- 6.3.1.1. U.S.
- 6.3.1.1.1. Advanced Therapy Medicinal Products Market: By Therapy Type, 2022-2032, USD (Million)
- 6.3.1.2. Canada
- 6.3.1.2.1. Advanced Therapy Medicinal Products Market: By Therapy Type, 2022-2032, USD (Million)
- 6.3.1.3. Rest of North America
- 6.3.1.3.1. Advanced Therapy Medicinal Products Market: By Therapy Type, 2022-2032, USD (Million)
- 6.3.1.1. U.S.
- 6.3.1.North America
7. UK and European Union Advanced Therapy Medicinal Products Market, 2022-2032, USD (Million)
- 7.1. Market Overview
- 7.2. Advanced Therapy Medicinal Products Market: By Therapy Type, 2022-2032, USD (Million)
- 7.3.Advanced Therapy Medicinal Products Market: By Region, 2022-2032, USD (Million)
- 7.3.1.UK and European Union
- 7.3.1.1. UK
- 7.3.1.1.1. Advanced Therapy Medicinal Products Market: By Therapy Type, 2022-2032, USD (Million)
- 7.3.1.2. Germany
- 7.3.1.2.1. Advanced Therapy Medicinal Products Market: By Therapy Type, 2022-2032, USD (Million)
- 7.3.1.3. Spain
- 7.3.1.3.1. Advanced Therapy Medicinal Products Market: By Therapy Type, 2022-2032, USD (Million)
- 7.3.1.4. Italy
- 7.3.1.4.1. Advanced Therapy Medicinal Products Market: By Therapy Type, 2022-2032, USD (Million)
- 7.3.1.5. France
- 7.3.1.5.1. Advanced Therapy Medicinal Products Market: By Therapy Type, 2022-2032, USD (Million)
- 7.3.1.6. Rest of Europe
- 7.3.1.6.1. Advanced Therapy Medicinal Products Market: By Therapy Type, 2022-2032, USD (Million)
- 7.3.1.1. UK
- 7.3.1.UK and European Union
8. Asia Pacific Advanced Therapy Medicinal Products Market, 2022-2032, USD (Million)
- 8.1. Market Overview
- 8.2. Advanced Therapy Medicinal Products Market: By Therapy Type, 2022-2032, USD (Million)
- 8.3.Advanced Therapy Medicinal Products Market: By Region, 2022-2032, USD (Million)
- 8.3.1.Asia Pacific
- 8.3.1.1. China
- 8.3.1.1.1. Advanced Therapy Medicinal Products Market: By Therapy Type, 2022-2032, USD (Million)
- 8.3.1.2. Japan
- 8.3.1.2.1. Advanced Therapy Medicinal Products Market: By Therapy Type, 2022-2032, USD (Million)
- 8.3.1.3. India
- 8.3.1.3.1. Advanced Therapy Medicinal Products Market: By Therapy Type, 2022-2032, USD (Million)
- 8.3.1.4. Australia
- 8.3.1.4.1. Advanced Therapy Medicinal Products Market: By Therapy Type, 2022-2032, USD (Million)
- 8.3.1.5. South Korea
- 8.3.1.5.1. Advanced Therapy Medicinal Products Market: By Therapy Type, 2022-2032, USD (Million)
- 8.3.1.6. Rest of Asia Pacific
- 8.3.1.6.1. Advanced Therapy Medicinal Products Market: By Therapy Type, 2022-2032, USD (Million)
- 8.3.1.1. China
- 8.3.1.Asia Pacific
9. Latin America Advanced Therapy Medicinal Products Market, 2022-2032, USD (Million)
- 9.1. Market Overview
- 9.2. Advanced Therapy Medicinal Products Market: By Therapy Type, 2022-2032, USD (Million)
- 9.3.Advanced Therapy Medicinal Products Market: By Region, 2022-2032, USD (Million)
- 9.3.1.Latin America
- 9.3.1.1. Brazil
- 9.3.1.1.1. Advanced Therapy Medicinal Products Market: By Therapy Type, 2022-2032, USD (Million)
- 9.3.1.2. Mexico
- 9.3.1.2.1. Advanced Therapy Medicinal Products Market: By Therapy Type, 2022-2032, USD (Million)
- 9.3.1.3. Rest of Latin America
- 9.3.1.3.1. Advanced Therapy Medicinal Products Market: By Therapy Type, 2022-2032, USD (Million)
- 9.3.1.1. Brazil
- 9.3.1.Latin America
10. Middle East and Africa Advanced Therapy Medicinal Products Market, 2022-2032, USD (Million)
- 10.1. Market Overview
- 10.2. Advanced Therapy Medicinal Products Market: By Therapy Type, 2022-2032, USD (Million)
- 10.3.Advanced Therapy Medicinal Products Market: By Region, 2022-2032, USD (Million)
- 10.3.1.Middle East and Africa
- 10.3.1.1. GCC
- 10.3.1.1.1. Advanced Therapy Medicinal Products Market: By Therapy Type, 2022-2032, USD (Million)
- 10.3.1.2. Africa
- 10.3.1.2.1. Advanced Therapy Medicinal Products Market: By Therapy Type, 2022-2032, USD (Million)
- 10.3.1.3. Rest of Middle East and Africa
- 10.3.1.3.1. Advanced Therapy Medicinal Products Market: By Therapy Type, 2022-2032, USD (Million)
- 10.3.1.1. GCC
- 10.3.1.Middle East and Africa
11. Company Profile
- 11.1. Spark Therapeutics, Inc.
- 11.1.1. Company Overview
- 11.1.2. Financial Performance
- 11.1.3. Product Portfolio
- 11.1.4. Strategic Initiatives
- 11.2. Bluebird Bio, Inc.
- 11.2.1. Company Overview
- 11.2.2. Financial Performance
- 11.2.3. Product Portfolio
- 11.2.4. Strategic Initiatives
- 11.3. Novartis AG
- 11.3.1. Company Overview
- 11.3.2. Financial Performance
- 11.3.3. Product Portfolio
- 11.3.4. Strategic Initiatives
- 11.4. UniQure N.V.
- 11.4.1. Company Overview
- 11.4.2. Financial Performance
- 11.4.3. Product Portfolio
- 11.4.4. Strategic Initiatives
- 11.5. Celgene Corporation
- 11.5.1. Company Overview
- 11.5.2. Financial Performance
- 11.5.3. Product Portfolio
- 11.5.4. Strategic Initiatives
- 11.6. Gilead Lifesciences, Inc.
- 11.6.1. Company Overview
- 11.6.2. Financial Performance
- 11.6.3. Product Portfolio
- 11.6.4. Strategic Initiatives
- 11.7. Kolon TissueGene, Inc.
- 11.7.1. Company Overview
- 11.7.2. Financial Performance
- 11.7.3. Product Portfolio
- 11.7.4. Strategic Initiatives
- 11.8. JCR Pharmaceuticals Co., Ltd.
- 11.8.1. Company Overview
- 11.8.2. Financial Performance
- 11.8.3. Product Portfolio
- 11.8.4. Strategic Initiatives
- 11.9. MEDIPOST
- 11.9.1. Company Overview
- 11.9.2. Financial Performance
- 11.9.3. Product Portfolio
- 11.9.4. Strategic Initiatives
- 11.10. Vericel Corporation
- 11.10.1. Company Overview
- 11.10.2. Financial Performance
- 11.10.3. Product Portfolio
- 11.10.4. Strategic Initiatives
- 11.11. PHARMICELL Co., Ltd
- 11.11.1. Company Overview
- 11.11.2. Financial Performance
- 11.11.3. Product Portfolio
- 11.11.4. Strategic Initiatives
- 11.12. Organogenesis Inc.
- 11.12.1. Company Overview
- 11.12.2. Financial Performance
- 11.12.3. Product Portfolio
- 11.12.4. Strategic Initiatives
- 11.13. Other Notable Players
- 11.13.1. Company Overview
- 11.13.2. Financial Performance
- 11.13.3. Product Portfolio
- 11.13.4. Strategic Initiatives
List of Tables
- TABLE 1 Global Advanced Therapy Medicinal Products Market By Therapy Type, 2022-2032, USD (Million)
- TABLE 2 Global Advanced Therapy Medicinal Products Market By Cell Therapy, 2022-2032, USD (Million)
TABLE 3 North America Advanced Therapy Medicinal Products Market By Therapy Type, 2022-2032, USD (Million)
- TABLE 4 North America Advanced Therapy Medicinal Products Market By Cell Therapy, 2022-2032, USD (Million)
TABLE 5 U.S. Advanced Therapy Medicinal Products Market By Therapy Type, 2022-2032, USD (Million)
- TABLE 6 U.S. Advanced Therapy Medicinal Products Market By Cell Therapy, 2022-2032, USD (Million)
TABLE 7 Canada Advanced Therapy Medicinal Products Market By Therapy Type, 2022-2032, USD (Million)
- TABLE 8 Canada Advanced Therapy Medicinal Products Market By Cell Therapy, 2022-2032, USD (Million)
TABLE 9 Rest of North America Advanced Therapy Medicinal Products Market By Therapy Type, 2022-2032, USD (Million)
- TABLE 10 Rest of North America Advanced Therapy Medicinal Products Market By Cell Therapy, 2022-2032, USD (Million)
TABLE 11 UK and European Union Advanced Therapy Medicinal Products Market By Therapy Type, 2022-2032, USD (Million)
- TABLE 12 UK and European Union Advanced Therapy Medicinal Products Market By Cell Therapy, 2022-2032, USD (Million)
TABLE 13 UK Advanced Therapy Medicinal Products Market By Therapy Type, 2022-2032, USD (Million)
- TABLE 14 UK Advanced Therapy Medicinal Products Market By Cell Therapy, 2022-2032, USD (Million)
TABLE 15 Germany Advanced Therapy Medicinal Products Market By Therapy Type, 2022-2032, USD (Million)
- TABLE 16 Germany Advanced Therapy Medicinal Products Market By Cell Therapy, 2022-2032, USD (Million)
TABLE 17 Spain Advanced Therapy Medicinal Products Market By Therapy Type, 2022-2032, USD (Million)
- TABLE 18 Spain Advanced Therapy Medicinal Products Market By Cell Therapy, 2022-2032, USD (Million)
TABLE 19 Italy Advanced Therapy Medicinal Products Market By Therapy Type, 2022-2032, USD (Million)
- TABLE 20 Italy Advanced Therapy Medicinal Products Market By Cell Therapy, 2022-2032, USD (Million)
TABLE 21 France Advanced Therapy Medicinal Products Market By Therapy Type, 2022-2032, USD (Million)
- TABLE 22 France Advanced Therapy Medicinal Products Market By Cell Therapy, 2022-2032, USD (Million)
TABLE 23 Rest of Europe Advanced Therapy Medicinal Products Market By Therapy Type, 2022-2032, USD (Million)
- TABLE 24 Rest of Europe Advanced Therapy Medicinal Products Market By Cell Therapy, 2022-2032, USD (Million)
TABLE 25 Asia Advanced Therapy Medicinal Products Market By Therapy Type, 2022-2032, USD (Million)
- TABLE 26 Asia Advanced Therapy Medicinal Products Market By Cell Therapy, 2022-2032, USD (Million)
TABLE 27 China Advanced Therapy Medicinal Products Market By Therapy Type, 2022-2032, USD (Million)
- TABLE 28 China Advanced Therapy Medicinal Products Market By Cell Therapy, 2022-2032, USD (Million)
TABLE 29 Japan Advanced Therapy Medicinal Products Market By Therapy Type, 2022-2032, USD (Million)
- TABLE 30 Japan Advanced Therapy Medicinal Products Market By Cell Therapy, 2022-2032, USD (Million)
TABLE 31 India Advanced Therapy Medicinal Products Market By Therapy Type, 2022-2032, USD (Million)
- TABLE 32 India Advanced Therapy Medicinal Products Market By Cell Therapy, 2022-2032, USD (Million)
TABLE 33 Australia Advanced Therapy Medicinal Products Market By Therapy Type, 2022-2032, USD (Million)
- TABLE 34 Australia Advanced Therapy Medicinal Products Market By Cell Therapy, 2022-2032, USD (Million)
TABLE 35 South Korea Advanced Therapy Medicinal Products Market By Therapy Type, 2022-2032, USD (Million)
- TABLE 36 South Korea Advanced Therapy Medicinal Products Market By Cell Therapy, 2022-2032, USD (Million)
TABLE 37 Latin America Advanced Therapy Medicinal Products Market By Therapy Type, 2022-2032, USD (Million)
- TABLE 38 Latin America Advanced Therapy Medicinal Products Market By Cell Therapy, 2022-2032, USD (Million)
TABLE 39 Brazil Advanced Therapy Medicinal Products Market By Therapy Type, 2022-2032, USD (Million)
- TABLE 40 Brazil Advanced Therapy Medicinal Products Market By Cell Therapy, 2022-2032, USD (Million)
TABLE 41 Mexico Advanced Therapy Medicinal Products Market By Therapy Type, 2022-2032, USD (Million)
- TABLE 42 Mexico Advanced Therapy Medicinal Products Market By Cell Therapy, 2022-2032, USD (Million)
TABLE 43 Rest of Latin America Advanced Therapy Medicinal Products Market By Therapy Type, 2022-2032, USD (Million)
- TABLE 44 Rest of Latin America Advanced Therapy Medicinal Products Market By Cell Therapy, 2022-2032, USD (Million)
TABLE 45 Middle East and Africa Advanced Therapy Medicinal Products Market By Therapy Type, 2022-2032, USD (Million)
- TABLE 46 Middle East and Africa Advanced Therapy Medicinal Products Market By Cell Therapy, 2022-2032, USD (Million)
TABLE 47 GCC Advanced Therapy Medicinal Products Market By Therapy Type, 2022-2032, USD (Million)
- TABLE 48 GCC Advanced Therapy Medicinal Products Market By Cell Therapy, 2022-2032, USD (Million)
TABLE 49 Africa Advanced Therapy Medicinal Products Market By Therapy Type, 2022-2032, USD (Million)
- TABLE 50 Africa Advanced Therapy Medicinal Products Market By Cell Therapy, 2022-2032, USD (Million)
TABLE 51 Rest of Middle East and Africa Advanced Therapy Medicinal Products Market By Therapy Type, 2022-2032, USD (Million)
- TABLE 52 Rest of Middle East and Africa Advanced Therapy Medicinal Products Market By Cell Therapy, 2022-2032, USD (Million)
List of Figures
- FIG. 1 Global Advanced Therapy Medicinal Products Market: Market Coverage
- FIG. 2 Research Methodology and Data Sources
- FIG. 3 Market Size Estimation - Top Down & Bottom-Up Approach
- FIG. 4 Global Advanced Therapy Medicinal Products Market: Quality Assurance
- FIG. 5 Global Advanced Therapy Medicinal Products Market, By Therapy Type, 2023
- FIG. 6 Global Advanced Therapy Medicinal Products Market, By Geography, 2023
- FIG. 7 Market Geographical Opportunity Matrix - Global Advanced Therapy Medicinal Products Market, 2023
FIG. 8Market Positioning of Key Advanced Therapy Medicinal Products Market Players, 2023
FIG. 9Global Advanced Therapy Medicinal Products Market - Tier Analysis - Percentage of Revenues by Tier Level, 2023 Versus 2032
- FIG. 10 Global Advanced Therapy Medicinal Products Market, By Therapy Type, 2023 Vs 2032, %
- FIG. 11 U.S. Advanced Therapy Medicinal Products Market (US$ Million), 2022 - 2032
- FIG. 12 Canada Advanced Therapy Medicinal Products Market (US$ Million), 2022 - 2032
- FIG. 13 Rest of North America Advanced Therapy Medicinal Products Market (US$ Million), 2022 - 2032
- FIG. 14 UK Advanced Therapy Medicinal Products Market (US$ Million), 2022 - 2032
- FIG. 15 Germany Advanced Therapy Medicinal Products Market (US$ Million), 2022 - 2032
- FIG. 16 Spain Advanced Therapy Medicinal Products Market (US$ Million), 2022 - 2032
- FIG. 17 Italy Advanced Therapy Medicinal Products Market (US$ Million), 2022 - 2032
- FIG. 18 France Advanced Therapy Medicinal Products Market (US$ Million), 2022 - 2032
- FIG. 19 Rest of Europe Advanced Therapy Medicinal Products Market (US$ Million), 2022 - 2032
- FIG. 20 China Advanced Therapy Medicinal Products Market (US$ Million), 2022 - 2032
- FIG. 21 Japan Advanced Therapy Medicinal Products Market (US$ Million), 2022 - 2032
- FIG. 22 India Advanced Therapy Medicinal Products Market (US$ Million), 2022 - 2032
- FIG. 23 Australia Advanced Therapy Medicinal Products Market (US$ Million), 2022 - 2032
- FIG. 24 South Korea Advanced Therapy Medicinal Products Market (US$ Million), 2022 - 2032
- FIG. 25 Rest of Asia Advanced Therapy Medicinal Products Market (US$ Million), 2022 - 2032
- FIG. 26 Brazil Advanced Therapy Medicinal Products Market (US$ Million), 2022 - 2032
- FIG. 27 Mexico Advanced Therapy Medicinal Products Market (US$ Million), 2022 - 2032
- FIG. 28 Rest of Latin America Advanced Therapy Medicinal Products Market (US$ Million), 2022 - 2032
- FIG. 29 GCC Advanced Therapy Medicinal Products Market (US$ Million), 2022 - 2032
- FIG. 30 Africa Advanced Therapy Medicinal Products Market (US$ Million), 2022 - 2032
- FIG. 31 Rest of Middle East and Africa Advanced Therapy Medicinal Products Market (US$ Million), 2022 - 2032
